SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-049976
Filing Date
2024-04-22
Accepted
2024-04-22 16:06:21
Documents
19
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242793d2_def14a.htm   iXBRL DEF 14A 984985
6 GRAPHIC sg_jillcmilne-bw.jpg GRAPHIC 5617
7 GRAPHIC bc_capandtsr-4c.jpg GRAPHIC 55732
8 GRAPHIC bc_capandnetincome-4c.jpg GRAPHIC 64738
9 GRAPHIC px_24astriaproxy1pg1-bw.jpg GRAPHIC 301182
10 GRAPHIC px_24astriaproxy1pg2-bw.jpg GRAPHIC 369099
  Complete submission text file 0001104659-24-049976.txt   3800266

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxs-20231231.xsd EX-101.SCH 7547
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxs-20231231_def.xml EX-101.DEF 6141
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20231231_lab.xml EX-101.LAB 24515
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20231231_pre.xml EX-101.PRE 5319
22 EXTRACTED XBRL INSTANCE DOCUMENT tm242793d2_def14a_htm.xml XML 199128
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 24861235
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)